Searching for reliable epidermal growth factor receptor response predictors -: Commentary re M. K.!Nyati et al., radiosensitization by pan-ErbB inhibitor CI-1033 in vitro and in vivo.: Clin. Cancer Res., 10: 691-700, 2004.

被引:8
作者
Harari, PM
Huang, SM
机构
[1] Univ Wisconsin, Ctr Comprehens Canc, Dept Human Oncol, Madison, WI 53792 USA
[2] Ctr Comprehens Canc, Madison, WI USA
关键词
D O I
10.1158/1078-0432.CCR-1220-03
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:428 / 432
页数:5
相关论文
共 45 条
[1]  
AMADOR ML, 2003, P AN M AM SOC CLIN, V22, P213
[2]   Targeting HERI/EGFR: A molecular approach to cancer therapy [J].
Arteaga, C .
SEMINARS IN ONCOLOGY, 2003, 30 (03) :3-14
[3]  
Arteaga CL, 2003, CLIN CANCER RES, V9, P1231
[4]  
Baker CH, 2002, CANCER RES, V62, P1996
[5]  
Baselga J, 2000, SEMIN ONCOL, V27, P27
[6]  
Bianco C, 2002, CLIN CANCER RES, V8, P3250
[7]  
Chakravarti A, 2002, CANCER RES, V62, P4307
[8]  
Chinnaiyan P., 2003, International Journal of Radiation Oncology Biology Physics, V57, pS294, DOI 10.1016/S0360-3016(03)01153-2
[9]   Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs [J].
Ciardiello, F ;
Tortora, G .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (10) :1348-1354
[10]  
COHEN S, 1983, CANCER-AM CANCER SOC, V51, P1787, DOI 10.1002/1097-0142(19830515)51:10<1787::AID-CNCR2820511004>3.0.CO